Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
Luigi Cavanna, Chiara Citterio, Ilaria Toscani
Vaccines (2021) Vol. 9, Iss. 9, pp. 1048-1048
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews
Kay Choong See
Vaccines (2022) Vol. 10, Iss. 5, pp. 800-800
Open Access | Times Cited: 36
COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis
K.I.P. Prabani, Ishanka Weerasekara, H. D. W. T. Damayanthi
Public Health (2022) Vol. 212, pp. 66-75
Open Access | Times Cited: 34
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Juan Ignacio Ruiz, María A. López-Olivo, Yimin Geng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006246-e006246
Open Access | Times Cited: 19
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 577-584
Open Access | Times Cited: 39
Higher COVID-19 Vaccination Rates Are Associated with Lower COVID-19 Mortality: A Global Analysis
Ilir Hoxha, Riaz Agahi, Altina Bimbashi, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 74-74
Open Access | Times Cited: 26
Cancer Patients during COVID-19 Pandemic: A Mini-Review
Maryam Linjawi, Hira Shakoor, Serene Hilary, et al.
Healthcare (2023) Vol. 11, Iss. 2, pp. 248-248
Open Access | Times Cited: 14
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium
Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 3, pp. e143-e152
Open Access | Times Cited: 20
Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients
Shijun Xin, Wei Chen, Qilin Yu, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 4
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, et al.
European Journal of Cancer (2022) Vol. 165, pp. 174-183
Open Access | Times Cited: 19
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
Carolin Krekeler, Lea Reitnauer, Ulrike Bacher, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5512-5512
Open Access | Times Cited: 18
Neutralizing antibody responses to three XBB protein vaccines in older adults
Guo‐Jian Yang, Mei Lu, Rui-Rui Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Yifei Ma, Nianqi Liu, Youlong Wang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003712-e003712
Open Access | Times Cited: 22
Herpes Zoster Following the COVID-19 Vaccination in Breast Cancer Long Time Survivor Patients
Ilaria Toscani, Albina Troiani, Chiara Citterio, et al.
Cureus (2021)
Open Access | Times Cited: 21
Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis
Ikhwan Rinaldi, Samuel Pratama, Lowilius Wiyono, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Jean‐Eudes Fahrner, Imran Lahmar, Anne‐Gaëlle Goubet, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 958-983
Open Access | Times Cited: 15
Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
Marta Sisteré‐Oró, Naína Andrade, Diana D. J. Wortmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Hesitant or not: A cross-sectional study of socio-demographics, conspiracy theories, trust in public health information, social capital and vaccine hesitancy among older adults in Ghana
Anthony Kwame Morgan, Modesta Akipase Aziire, Justin Cobbold, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
Angioletta Lasagna, Daniele Lilleri, Francesco Agustoni, et al.
ESMO Open (2021) Vol. 7, Iss. 1, pp. 100359-100359
Open Access | Times Cited: 16
A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA
Andhika Rachman, Anggraini Iriani, Lugyanti Sukrisman, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281907-e0281907
Open Access | Times Cited: 6
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6
Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among Chinese cancer patients: A multicentre cross-sectional survey
Lei Zhang, Jianzhou Yang, Rila Su, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 6
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety
Luigi Cavanna, Manuela Proietto, Chiara Citterio, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 164-164
Open Access | Times Cited: 8
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
Fabio Turco, Andrew J. Armstrong, Gerhardt Attard, et al.
European Urology (2022) Vol. 82, Iss. 1, pp. 6-11
Open Access | Times Cited: 8
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients
Beatriz Almeida, Tânia R. Dias, Pedro Cruz, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 848-848
Open Access | Times Cited: 1
COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews
Hong Sun, Fengjiao Bu, Ling Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top